Seeing Is Believing
with an average price target of $6.21. This is a potential upside of $6.21 (0%) from yesterday's end of day stock price of $0.
Silverback Therapeutics 's activity chart (see below) currently has 15 price targets and 18 ratings on display.
Analysts average stock forecasts to be materialized ratio is 55% with an average time for these price targets to be met of 31.2 days.
Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 13-May-2022. First documented stock forecast 29-Dec-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$5
$-0.87 (-14.82%)
$6
2 years 7 months 4 days ago
(13-May-2022)
3/4 (75%)
$2.04 (68.92%)
121
Hold
$1.8
$-4.07 (-69.34%)
$25
2 years 8 months 16 days ago
(01-Apr-2022)
1/3 (33.33%)
$-1.41 (-43.93%)
1
Hold
$3.5
$-2.37 (-40.37%)
$48
2 years 8 months 16 days ago
(01-Apr-2022)
2/3 (66.67%)
$0.29 (9.03%)
32
Hold
$50
2 years 8 months 16 days ago
(01-Apr-2022)
0/1 (0%)
$23.14 (86.15%)
Hold
$44
2 years 8 months 16 days ago
(01-Apr-2022)
1/1 (100%)
$7 (18.92%)
2
What is SBTX (Silverback Therapeutics ) average time for price targets to be met?
Which analyst has the current highest performing score on SBTX (Silverback Therapeutics ) with a proven track record?
Which analyst has the current lower performing score on SBTX (Silverback Therapeutics ) with a proven track record?
Which analyst has the most public recommendations on SBTX (Silverback Therapeutics )?
Which analyst is the currently most bullish on SBTX (Silverback Therapeutics )?
Which analyst is the currently most reserved on SBTX (Silverback Therapeutics )?